Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Washington University School of Medicine
Institute of Hematology & Blood Diseases Hospital, China
Baylor College of Medicine
Children's Oncology Group
Princess Maxima Center for Pediatric Oncology
Shanghai Jiao Tong University School of Medicine
Peking University People's Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.